Intervertebral disk degeneration and emerging biologic treatments

Journal of the American Academy of Orthopaedic Surgeons

Volumn 19, Issue 9, 2011, Pages 543-553

  Kepler, Christopher K ^a   Anderson, D Greg ^a   Tannoury, Chadi ^a   Ponnappan, Ravi K ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80053578695     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/00124635-201109000-00005     Document Type: Review

References (66)

1. Ganey T, Libera J, Moos V, et al: Disc chondrocyte transplantation in a canine model: A treatment for degenerated or damaged intervertebral disc. Spine (Phila Pa 1976) 2003;28(23):2609-2620. (Pubitemid 37490470)
2. Hohaus C, Ganey TM, Minkus Y, Meisel HJ: Cell transplantation in lumbar spine disc degeneration disease. Eur Spine J 2008;17(suppI4):492-503.
3. Omlor GW, Bertram H, Kleinschmidt K, et al: Methods to monitor distribution and metabolic activity of mesenchymal stem cells following in vivo injection into nucleotomized porcine intervertebral discs. Eur Spine J 2010;19(4):601-612.
4. Henriksson HB, Svanvik T, Jonsson M, et al: Transplantation of human mesenchymal stems cells into intervertebral discs in a xenogeneic porcine model. Spine (Phila Pa 1976) 2009;34(2):141-148.
5. Barendse GA, van Den Berg SG, Kessels AH, Weber WE, van Kleef M: Randomized controlled trial of percutaneous intradiscal radiofrequency thermocoagulation for chronic discogenic back pain: Lack of effect from a 90-second 70 C lesion. Spine (Phila Pa 1976; 2001;26(3):287-292.
6. Erçelen O, Bulutçu E, Oktenoglu T, et al: Radiofrequency lesioning using two different time modalities for the treatment of lumbar discogenic pain: A randomized trial. Spine (Phila Pa 1976) 2003;28(17):1922- 1927. (Pubitemid 37082654)
7. An HS, Takegami K, Kamada H, et al: Intradiscal administration of osteogenic protein-1 increases intervertebral disc height and proteoglycan content in the nucleus pulposus in normal adolescent rabbits. Spine (Phila Pa 1976) 2005; 30(1):25-31. (Pubitemid 40209272)
8. Chubinskaya S, Kawakami M, Rappoport L, Matsumoto T, Migita N, Rueger DC: Anti-catabolic effect of OP-1 in chronically compressed intervertebral discs. J Orthop Res 2007;25(4):517-530. (Pubitemid 46542040)
9. Chujo T, An HS, Akeda K, et al: Effects of growth differentiation factor-S on the intervertebral disc: In vitro bovine study and in vivo rabbit disc degeneration model study. Spine (Phila Pa 1976) 2006;31(25):2909-2917. (Pubitemid 44885707)
10. Cui M, Wan Y, Anderson DG, et al: Mouse growth and differentiation factor-5 protein and DNA therapy potentiates intervertebral disc cell aggregation and chondrogenic gene expression. Spine J 2008;8(2):287-295. (Pubitemid 351735986)
11. Zhang Y, Markova D, Im HJ, et al: Primary bovine intervertebral disc cells transduced with adenovirus overexpressing 12 BMPs and Sox9 maintain appropriate phenotype. Am J Phys Med Rehabil 2009;88(6):455-463.
12. Nishida K, Kang JD, Gilbertson LG, et al: Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: An in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine (Phila Pa 1976) 1999;24(23):2419-2425. (Pubitemid 30002977)
13. Liang H, Ma SY, Feng G, Shen FH, Joshua Li X: Therapeutic effects of adenovirus-mediated growth and differentiation factor-S in a mice disc degeneration model induced by annulus needle puncture. Spine J 2010;10(1):32-41.
14. Choi YS: Pathophysiology of degenerative disc disease. Asian Spine J 2009;3(1):39-44.
15. Buckwalter JA: Aging and degeneration of the human intervertebral disc. Spine (Phila Pa 1976) 1995;20(11):1307-1314.
16. Pfirrmann CW, Metzdorf A, Zanetti M, Hodler J, Boos N: Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine (Phila Pa 1976) 2001;26(17):1873-1878. (Pubitemid 32844681)
17. Le Maitre CL, Freemont AJ, Hoyland JA: Accelerated cellular senescence in degenerate intervertebral discs: A possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther 2007;9(3):R45.
18. Pearce RH, Grimmer BJ, Adams ME: Degeneration and the chemical composition of the human lumbar intervertebral disc. J Orthop Res 1987; 5(2):198-205. (Pubitemid 17088147)
19. Antoniou J, Steffen T, Nelson F, et al: The human lumbar intervertebral disc: Evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. J Clin Invest 1996; 98(4):996-1003. (Pubitemid 26293318)
20. Nerlich AG, Schleicher ED, Boos N: 1997 Volvo Award winner in basic science studies: Immunohistologic markers for age-related changes of human lumbar intervertebral discs. Spine (Phila Pa 1976) 1997;22(24):2781-2795. (Pubitemid 28070623)
21. Cs-Szabo G, Ragasa-San Juan D, Turumella V, Masuda K, Thonar EJ, An HS: Changes in mRNA and protein levels of proteoglycans of the anulus fibrosus and nucleus pulposus during intervertebral disc degeneration. Spine (Phila Pa 1976) 2002;27(20):2212-2219. (Pubitemid 35192359)
22. Sive JI, Baird P, Jeziorsk M, Watkins A, Hoyland JA, Freemont AJ: Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol 2002;S5(2):91-97. (Pubitemid 34293410)
23. Duance VC, Crean JK, Sims TJ, et al: Changes in collagen cross-linking in degenerative disc disease and scoliosis. Spine (Phila Pa 1976) 1998;23(23): 2545-2551. (Pubitemid 29003528)
24. Nishimura K, Mochida J: Percutaneous reinsertion of the nucleus pulposus: An experimental study. Spine (Phila Pa 1976) 1998;23(14):1531-1538.
25. Nomura T, Mochida J, Okuma M, Nishimura K, Sakabe K: Nucleus pulposus allograft retards intervertebral disc degeneration. Clin Orthop Relat Res 2001;(389):94-101. (Pubitemid 32729644)
26. Gruber HE, Johnson TL, Leslie K, et al: Autologous intervertebral disc cell implantation: A model using Psammomys obesus, the sand rat. Spine (Phila Pa 1976) 2002;27(15): 1626-1633. (Pubitemid 34839645)
27. Reza AT, Nicoll SB: Characterization of novel photocrosslinked carboxymethyl-cellulose hydrogels for encapsulation of nucleus pulposus cells. Acta Biomater 2010;6(1):179-186.
28. Risbud MV, Albert TJ, Guttapalli A, et al: Differentiation of mesenchymal stem cells towards a nucleus puiposus-like phenotype in vitro: Implications for cell-based transplantation therapy. Spine (Phila Pa 1976) 2004;29(23):2627- 2632. (Pubitemid 40353248)
29. Zhang YG, Guo X, Xu P, Kang LL, Li J: Bone mesenchymal stem cells transplanted into rabbit intervertebral discs can increase proteoglycans. Clin Orthop Relat Res 2005;(430):219-226. (Pubitemid 40096155)
30. Sakai D, Mochida J, Iwashina T, et al: Regenerative effects of transplanting mesenchymal stem cells embedded in atelocollagen to the degenerated intervertebral disc. Biomaterials 2006; 27(3):335-345. (Pubitemid 41457236)
31. Yoshikawa T, Ueda Y, Miyazaki K, Koizumi M, Takakura Y: Disc regeneration therapy using marrow mesenchymal cell transplantation: A report of two case studies. Spine (Phila Pa 1976) 2010;35(11):E475-E480.
32. Nagae M, Ikeda T, Mikami Y, et al: Intervertebral disc regeneration using platelet-rich plasma and biodegradable gelatin hydrogel microspheres. Tissue Eng 2007;13(1):147-158. (Pubitemid 46175536)
33. Sawamura K, Ikeda T, Nagae M, et al: Characterization of in vivo effects of platelet-rich plasma and biodegradable gelatin hydrogel microspheres on degenerated intervertebral discs. Tissue Eng Part A 2009;15(12):3719-3727.
34. Freemont AJ, Peacock TE, Goupille P, Hoyland JA, O'Brien J, Jayson MI: Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet 1997;350(9072):178-181. (Pubitemid 27303625)
35. Johnson WE, Caterson B, Eisenstein SM, Hynds DL, Snow DM, Roberts S: Human intervertebral disc aggrecan inhibits nerve growth in vitro. Arthritis Rheum 2002;46(10):2658-2664. (Pubitemid 36118929)
36. Freemont AJ, Watkins A, Le Maitre C, et al: Nerve growth factor expression and innervation of the painful intervertebral disc. J Pathol 2002;197(3): 286-292. (Pubitemid 34778297)
37. Purmessur D, Freemont AJ, Hoyland JA: Expression and regulation of neurotrophins in the nondegenerate and degenerate human intervertebral disc. Arthritis Res Ther 2008;10(4):R99.
38. Freeman BJ, Fraser RD, Cain CM, Hall DJ, Chappie DC: A randomized, double-blind, controlled trial: Intradiscal electrothermal therapy versus placebo for the treatment of chronic discogenic low back pain. Spine (Phila Pa 1976) 2005;30(21):2369-2377. (Pubitemid 41568740)
39. Pauza KJ, Howell S, Dreyfuss P, Peloza JH, Dawson K, Bogduk N: A randomized, placebo-controlled trial of intradiscal electrothermal therapy for the treatment of discogenic low back pain. Spine J 2004;4(1):27-35. (Pubitemid 38100898)
40. Tolonen J, Grönblad M, Vanharanta H, et al: Growth factor expression in degenerated intervertebral disc tissue: An immunohistochemical analysis of transforming growth factor beta, fibroblast growth factor and platelet-derived growth factor. Eur Spine J 2006; 15(5):588-596.
41. Murakami H, Yoon ST, Attallah-Wasif ES, Tsai KJ, Fei Q, Hutton WC: The expression of anabolic cytokines in intervertebral discs in age-related degeneration. Spine (Phila Pa 1976) 2006;31(16):1770-1774. (Pubitemid 44079501)
42. Tolonen J, Grönblad M, Virri J, Seitsalo S, Rytömaa T, Karaharju E: Basic fibroblast growth factor immuno-reactivity in blood vessels and cells of disc herniations. Spine (Phila Pa 1976) 1995;20(3):271-276.
43. Doita M, Kanatani T, Harada T, Mizuno K: Immunohistologic study of the ruptured intervertebral disc of the lumbar spine. Spine (Phila Pa 1976) 1996;21(2):235-241. (Pubitemid 26041223)
44. Matsui Y, Maeda M, Nakagami W, Iwata H: The involvement of matrix metalloproteinases and inflammation in lumbar disc herniation. Spine (Phila Pa 1976) 1998;23(8):863-868.
45. Roberts S, Caterson B, Menage J, Evans EH, Jaffray DC, Eisenstein SM: Matrix metalloproteinases and aggrecanase: Their role in disorders of the human intervertebral disc. Spine (Phila Pa 1976) 2000;25(23):3005-3013.
46. Weiler C, Nerlich AG, Zipperer J, Bachmeier BE, Boos N: 2002 SSE Award Competition in Basic Science: Expression of major matrix metalloproteinases is associated with intervertebral disc degradation and resorption. Eur Spine J 2002;11(4):308-320. (Pubitemid 34983932)
47. Hatano E, Fujita T, Ueda Y, et al: Expression of ADAMTS-4 (aggrecanase-1) and possible involvement in regression of lumbar disc herniation. Spine (Phila Pa 1976) 2006; 31(13):1426-1432. (Pubitemid 43880188)
48. Le Maitre CL, Freemont AJ, Hoyland JA: The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 2005;7(4):R732-R745.
49. Shen B, Melrose J, Ghosh P, Taylor F: Induction of matrix metalloproteinase-2 and -3 activity in ovine nucleus pulposus cells grown in three-dimensional agarose gel culture by interleukin-1beta: A potential pathway of disc degeneration. Eur Spine J 2003;12(1):66-75. (Pubitemid 36286833)
50. Jimbo K, Park JS, Yokosuka K, Sato K, Nagata K: Positive feedback loop of interleukin-1 beta upregulating production of inflammatory mediators in human intervertebral disc cells in vitro. J Neurosurg Spine 2005;2(5):589-595.
51. Cui LY, Liu SL, Ding Y, et al: IL-1beta sensitizes rat intervertebral disc cells to Fas ligand mediated apoptosis in vitro. Acta Pharmacol Sin 2007;28(10):1671-1676. (Pubitemid 47493292)
52. Zhao CQ, Liu D, Li H, Jiang LS, Dai LY: Interleukin-1beta enhances the effect of scrum deprivation on rat annular cell apoptosis. Apoptosis 2007;12(12):2155-2161. (Pubitemid 350077251)
53. Séguin CA, Pilliar RM, Roughley PJ, Kandel RA: Tumor necrosis factor-alpha modulates matrix production and catabolism in nucleus pulposus tissue. Spine (Phila Pa 1976) 2005;30(17): 1940-1948. (Pubitemid 41292217)
54. Freemont AJ: The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain. Rheumatology (Oxford) 2009;48(1):5-10.
55. Olmarker K, Nordborg C, Larsson K, Rydevik B: Ultrastructural changes in spinal nerve roots induced by autologous nucleus pulposus. Spine (Phila Pa 1976) 1996;21(4):411-414. (Pubitemid 26067847)
56. Kang JD, Georgescu HI, McIntyre-Larkin L, Stefanovic-Racic M, Donaldson WF III, Evans CH: Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine (Phila Pa 1976) 1996;21(3):271-277. (Pubitemid 26056478)
57. Burke JG, Watson RW, McCormack D, Dowling FE, Walsh MG, Fitzpatrick JM: Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br 2002;84(2):196-201. (Pubitemid 34257682)
58. Ahn SH, Cho YW, Ahn MW, Jang SH, Sohn YK, Kim HS: mRNA expression of cytokines and chemokines in herniated lumbar intervertebral discs. Spine (Phila Pa 1976) 2002;27(9):911-917.
59. Kawakami M, Matsumoto T, Hashizume H, Kuribayashi K, Chubinskaya S, Yoshida M: Osteogenic protein-1 (osteogenic protein-1/bone morphogenetic protein-7) inhibits degeneration and pain-related behavior induced by chronically compressed nucleus pulposus in the rat. Spine (Phila Pa 1976) 2005;30(17):1933-1939. (Pubitemid 41292216)
60. Masuda K, Imai Y, Okuma M, et al: Osteogenic protein-1 injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit anular puncture model. Spine (Phila Pa 1976) 2006;31(7):742-754.
61. Imai Y, Okuma M, An HS, et al: Restoration of disc height loss by recombinant human osteogenic protein-1 injection into intervertebral discs undergoing degeneration induced by an intradiscal injection of chondroitinase ABC. Spine (Phila Pa 1976) 2007; 32(11):1197-1205. (Pubitemid 46743020)
62. Walsh AJ, Bradford DS, Lotz JC: In vivo growth factor treatment of degenerated intervertebral discs. Spine (Phila Pa 1976) 2004;29(2):156-163. (Pubitemid 38112496)
63. Genevay S, Finckh A, Mezin F, Tessitore E, Guerne PA: Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation. Arthritis Res Ther 2009; 11(6):R169.
64. Nishida K, Kang JD, Suh JK, Robbins PD, Evans CH, Gilbertson LG: Adenovirus-mediated gene transfer to nucleus pulposus cells: Implications for the treatment of intervertebral disc degeneration. Spine (Phila Pa 1976) 1998;23(22):2437-2442.
65. Le Maitre CL, Hoyland JA, Freemont AJ: Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: An in situ zymographic and gene therapy study. Arthritis Res Ther 2007;9(4):R83.
66. Moon SH, Nishida K, Gilbertson LG, et al: Biologic response of human intervertebral disc cells to gene therapy cocktail. Spine (Phila Pa 1976) 2008; 33(17):1850-1855.